$6.15
-0.20-3.15%
At close: -
$6.15
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Nuvectis Pharma Earnings Estimates, EPS & Revenue | NASDAQ:NVCT | Benzinga
Nuvectis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.230
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Nuvectis Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Nuvectis Pharma (NVCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-0.36 | $-0.28 | -28.6 % |
| Q3 | 2024-11-05 | $-0.24 | $-0.25 | 4.00 % |
| Q2 | 2024-08-06 | $-0.26 | $-0.26 | 0.00 % |
| Q1 | 2024-05-07 | $-0.25 | $-0.40 | 37.5 % |
Nuvectis Pharma (NVCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Nuvectis Pharma (NASDAQ:NVCT) reporting earnings?
Nuvectis Pharma (NVCT) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Nuvectis Pharma (NASDAQ:NVCT)?
The Actual EPS was $-0.36, which missed the estimate of $-0.28.
What were Nuvectis Pharma’s (NASDAQ:NVCT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.